Blar i forfatter "Flores, Lizbett"
-
Exploring Personality and Readiness to Change in Patients With Substance Use Disorders With and Without ADHD
Flores, Lizbett; Ytterstad, Elinor; Lensing, Michael B.; Eisemann, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2016)<p><i>Objective</i>: To explore personality and readiness to change among substance use disorders (SUD) patients with and without ADHD.</p> <p><i>Method</i>: SUD + ADHD versus SUD − ADHD patients consecutively entering treatment between 2010 and 2012 were compared concerning personality (Temperament and Character Inventory) and readiness to change (Stages of Change Readiness and Treatment Eagerness ... -
Positive and negative aspects of substance use and treatment goals among substance use disorder patients with and without attention deficit hyperactivity disorder: A qualitative study
Flores, Lizbett; Lensing, Michael B.; Bjerke, Trond Nergaard; Kvalnes, Martin; Eisemann, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-11-11)There is limited research on the perceptions of substance use (SU) and treatment goals among patients with substance use disorders (SUD) and attention deficit hyperactivity disorder (ADHD). We investigate whether SU perceptions and treatment goals were different among SUD patients with (SUD+ADHD) and without (SUD-ADHD) ADHD. Twelve SUD+ADHD patients (39.5 ± 8.5 years, 10 men), and 10 age- and substance ... -
Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study
Flores, Lizbett; Lensing, Michael B.; Ytterstad, Elinor; Eisemann, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-03-22)There is sparse research on quality of life (QoL) as an outcome measure in patients with substance use disorders (SUD), with or without attention deficit hyperactivity disorder (ADHD). We aimed to investigate whether SUD patients with and without ADHD (SUD + ADHD vs. SUD − ADHD) differed in QoL at baseline and at a 12-month follow-up after SUD treatment. The groups were additionally compared with ...